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Bartha M KnoppersOn 28 January 2013, funders and researchers met to dis-
cuss how to enable rapid progress for biomedicine by low-
ering global barriers to responsible and secure data
sharing [1]. Since then, over 130 leading organizations in
health care, research and disease advocacy, operating in 40
countries, have signed a letter of intent to work towards
the creation of a Global Alliance for Genomics and Health
(GA4GH) [2]. There are three goals: to enable open stan-
dards for interoperability of technology platforms for m-
anaging and sharing genomic and clinical data, to provide
guidelines and harmonized procedures for privacy and
ethics internationally, and to engage stakeholders to
encourage responsible sharing of data and of methods.
After the mapping and sequencing of the human ge-
nome, today’s challenge is the integration of genomics
data with clinical data. However, interpretation of indi-
vidual sequences for genomic medicine requires an evi-
dence base of secure data sharing within a framework of
core principles. The GA4GH core principles are as fol-
lows: respect - protecting secure data sharing and pri-
vacy preferences of participants; transparency - ensuring
open governance and operations; accountability - promoting
best practices in technology, ethics and outreach; inclusivity -
partnering and building trust among stakeholders;
collaboration - sharing information to advance human
health; innovation - developing an ecosystem that accelerates
progress; agility - acting swiftly to benefit those with disease.
The vision of the GA4GH then is to promote and fa-
cilitate the exchange of extensive data on genomic se-
quences, including clinical annotations, to accelerate
progress in genomic medicine, such as for cancer out-
comes and targeted therapy, inherited pediatric diseases,
other common non-communicable diseases, infectious
diseases, and drug responses. In this short paper, we will
focus on the international ethics harmonization chal-
lenges that the GA4GH faces.Correspondence: bartha.knoppers@mcgill.ca
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For 2014, the short-term organizational goals of the
GA4GH are to establish an open and transparent struc-
ture with an executive and secretariat. Four Working
Groups will produce standards and documents that will
address the following areas: genomic data interoperabil-
ity; security and privacy of data; ethics and regulatory is-
sues; and clinical data. Relationships with cloud
computing operators that provide distributed informa-
tion platforms will allow the launch of transformative
demonstration projects, first, to create the technical
standards for data sharing and, second, to foster testing
of processes for the global harmonization of ethics
frameworks.
With respect to the first demonstration project, except
for disease-based efforts such as, for example, the
International Cancer Genome Consortium (ICGC,
http://www.icgc.org/) and the International Rare Dis-
eases Research Consortium (http://www.irdirc.org/), data
are still siloed and international standards for informat-
ics are missing or not up to scale. Although security and
privacy technologies are increasingly sophisticated, more
work needs to be done to create a system that recog-
nizes data producers and managers. Internationally rec-
ognized systems for the proper identification of the
provenance of bioresources and genomic and clinical
data, as well as scientific attribution for accompanying
analyses, are emerging [3,4]. Cloud computing operators
that agree to be platform development partners need to
establish both common standards and tools, including
the necessary software, as well as voluntary models of
self-regulation and certification. The GA4GH will chiefly
mobilize and catalyze these efforts to enable operators
and working groups to develop and implement inter-
operable application program interfaces and technologies.
However, for the second demonstration project, the
socio-ethical and legal regulatory challenges of such a
global initiative may prove to be formidable. Indeed,
although agreement on data standards and quality assu-
rance can (hopefully) be reached with leading. The licensee has exclusive rights to distribute this article, in any medium, for 12
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tems managers, consensus on even a standardized set of
acceptable processes and procedures for ethical, legal and
social implications (ELSI) using the core principles is not
certain. Ethics harmonization (as opposed to
standardization) may be achievable, however. To accom-
plish this, the GA4GH will have to maintain both a clear,
shared vision and interactive, dynamic communication
structures within a global membership that ranges from
public and academic, private and patient organizations to
policymakers [5]. Harmonizing ELSI tools across these
members and countries will not be simple.
International ethics harmonization
Narrow practices for consent and for privacy protection
thwart international exchange. Although international
genomics projects such as the ICGC and international
consortia such as the Public Population Project in Geno-
mics and Society have worked towards harmonizing ethics
approaches, be it for broad consent forms or data and
sample access agreements [6], challenges in international
uptake remain. Specifically, data are still too often analyzed
in isolated disciplinary or institutional silos and with in-
compatible methods. Regulatory systems still are neither
designed nor sufficiently updated to foster widespread
cross-study collaboration and trans-border open sharing
of data. As such, the continued absence of harmonized
ethics norms that can facilitate internationally collabo-
rative global science and responsible research may be the
major challenge as the GA4GH attempts to enable the
translational transformation of the fruits of public invest-
ment in genomics and biomedical research.
Ethics harmonization needs to recognize legal and cul-
tural diversity but remain principled and practical. Thus,
the core principles of the GA4GH need to be translated
into processes and procedures that facilitate the mutual
recognition of ethics review in different countries, avoi-
ding conflicting and inconsistent approaches while retai-
ning the benefits of expert ethics review. We recently
proposed a ‘safe harbor’ framework for international ethics
review governance [7]. Such a safe harbor model has been
used for the recognition of the equivalency of privacy pro-
tections following the adoption of the European Privacy
Directive in 1995. If adopted for ethics review of data-
driven international research projects, it could streamline
the current fragmented, inconsistent and inefficient ‘sys-
tem’. Considering that GA4GH seeks to integrate genomic
data with clinical data for research and eventual translation
into treatment, such mutual recognition of the adequacy
(albeit different) approaches of countries to ethics review is
but a first step. The next would be to actually put in place a
federated system for ethics review. A cornerstone for such
a process would be an international data sharing ‘Code of
Conduct’ that could be a beginning for this harmonizationprocess [8]. Cloud computing contributors, producers, op-
erators and users of genomic and clinical data could pledge
to adhere to such a Code of Conduct. To ensure maximum
effectiveness, the Code could be founded on international
human rights policies that are already globally ratified and
that currently serve to guide and delimit national laws.
A human rights approach would not only bolster already
accepted ethics principles [9] but also, more importantly,
provide a legal framework for enactment and
accountability.
Next steps
A Code of Conduct could serve to realize what until
now have been largely dormant human rights. Indeed, in
1948, article 27 of the Universal Declaration of Human
Rights proclaimed that ‘Everyone has the right to share
in scientific advancements and its benefits … and the
right to the protection of the moral and material inter-
ests resulting from any scientific … production of which
he is the author’ [10]. Herein lies the ideal, to create an
inclusive entity that responsibly creates frameworks and
tools for genomic and clinical data sharing, fosters the
translation of the benefits of research for health, and yet
recognizes the contribution of the scientists that make
this possible. In short, the GA4GH should engage,
encourage and enable, while maximizing ethical
harmonization to earn global endorsement and trust.
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